MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts payable and
other current...
$6,709,196
Depreciation and
amortization expense
$4,145,201
Inventories, net
-$2,242,616
Amortization of operating
lease right-of-use...
$1,140,738
Stock-based compensation
$408,320
Increase (decrease) in
non-cash contingent...
$46,569
Noncash interest
expense
$23,185
Loss on
co-commercialization investment
-$13,220
Net cash provided by
(used in) operating...
$4,932,522
Canceled cashflow
$9,796,523
Net decrease in cash
and cash...
-$6,519,491
Canceled cashflow
$4,932,522
Proceeds from atm
offering, net
-$5,266,334
Accounts receivable
$5,243,314
Net loss
-$2,864,711
Operating lease
liabilities
-$836,100
Other long-term
liabilities
-$477,642
Other current assets
and other assets
$231,829
Increase in cash
surrender value of life...
$142,927
Net cash provided by
(used in) financing...
-$6,745,516
Canceled cashflow
$5,266,334
Net cash provided by
(used in) investing...
-$4,706,497
Payments on line of credit
$10,035,437
Cash settlement of
contingent consideration
$1,712,935
Payments made in
connection with repurchase...
$263,478
Net investment in
manufacturing
$2,477,192
Other investment
$2,000,000
Additions to property and
equipment
$97,903
Additions to intangible
assets
$84,402
Increase in cash
surrender value of life...
$47,000
Back
Back
Cash Flow
source: myfinsight.com
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)